Covered recipient · General Payments record
SAIED EBRAHIM SHEMIRANEI
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2018–2024
$4,060.07
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $473.10 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $238.44 | 10 |
| Novo Nordisk AS | $133.42 | 2 |
| Alkermes, Inc. | $29.81 | 1 |
| Atland Pharmaceuticals, LLC | $26.25 | 1 |
| Gilead Sciences, Inc. | $23.75 | 1 |
| Averitas Pharma Inc. | $21.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.93 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081699 | CMS |
| ABBVIE INC. | $28.36 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081701 | CMS |
| ABBVIE INC. | $10.95 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081703 | CMS |
| ABBVIE INC. | $5.87 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081705 | CMS |
| ABBVIE INC. | $6.43 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081707 | CMS |
| ABBVIE INC. | $9.51 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081709 | CMS |
| ABBVIE INC. | $112.00 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081711 | CMS |
| ABBVIE INC. | $19.87 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081713 | CMS |
| ABBVIE INC. | $13.37 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081715 | CMS |
| ABBVIE INC. | $17.15 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081717 | CMS |
| Alkermes, Inc. | $29.81 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120596707 | CMS |
| Atland Pharmaceuticals, LLC | $26.25 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067526633 | CMS |
| Averitas Pharma Inc. | $21.43 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133446023 | CMS |
| Gilead Sciences, Inc. | $23.75 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133837480 | CMS |
| Novo Nordisk Inc | $21.42 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096948170 | CMS |
| Novo Nordisk Inc | $112.00 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097281198 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.